Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021

Wednesday, November 23, 2016 22:33
% of readers think this story is Fact. Add your two cents.

(Before It's News)

ReportsWeb.com has announced the addition of the “Global and China Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021”, the report focuses on global major leading industry players with information such as company profiles, product picture and specification.

The global Drugs for Treatment of Prostate Cancer market was valued at USD 43.47 Billion in 2015, and is projected to reach USD 52.16 Billion by 2021, at a CAGR of 9.99% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs

For more information about this report at http://www.reportsweb.com/global-and-china-drugs-for-treatment-of-prostate-cancer-research-report-2015-to-2021

This report studies Drugs for Treatment of Prostate Cancer in Global market, including Triptorelin, Leuprorelin, Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and Xtandi, focuses on price, sales, revenue of each type in global. This report also focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China, forecast to 2021, from 2015.And Zytiga took up 51.33% market share in 2015.

On basis of segments by Types, this report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers.

On basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Drugs for Treatment of Prostate Cancer, revenue and market share, for key manufacturers. The main manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda Pharmaceutical Company Limited, Schering-Plough Canada, S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.

On basis of segments by regions, this report focuses on the sales (consumption), production, import and export of Drugs for Treatment of Prostate Cancer in America, Established ROW, Western Europe, Emerging Markets, Russia and China.

Request a sample copy at http://www.reportsweb.com/inquiry&RW0001271077/sample

Other Key Points in the Report

On basis of segments by applications, this report focuses on consumption and growth rate of Drugs for Treatment of Prostate Cancer in major applications.

With 180 pages, 216 charts and eight chapters, to display the market present situation and future, clearly and deeply.

Ask for Discount at http://www.reportsweb.com/inquiry&RW0001271077/discount

Table of Content                                                                            

1 Drugs for Treatment of Prostate Cancer Overview and Each Type

2 Competition Analysis by Manufacturers in Global and China

3 Sales and Revenue Segments of Each Type 2010 to 2015

4 Market Segments and Forecast of Drugs for Treatment of Prostate Cancer by Regions

5 Raw Materials and Applications

6 Key Manufacturers Analysis of Drugs for Treatment of Prostate Cancer

6.1 IPSEN
6.1.1 IPSEN Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.1.4 Interviewee, Name and Contact

6.2 Ferring Pharmaceuticals
6.2.1 Company Basic Information
6.2.2 Triptorelin (Specification and Price)
6.2.3 Sales Value, Gross Margin 2011-2016
6.2.4 Interviewee, Name and Contact

6.3 Chengdu Tiantaishan pharmaceutical
6.3.1 Company Basic Information
6.3.2 Triptorelin (Specification and Price)
6.3.3 Sales Value, Gross Margin 2011-2016
6.3.4 Interviewee, Name and Contact

6.4 GeneScience Pharmaceuticals
6.4.1 Company Basic Information
6.4.2 Triptorelin (Specification and Price)
6.4.3 Sales Value, Gross Margin 2011-2016
6.4.4 Interviewee, Name and Contact

6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Basic Information
6.5.2 Leuprorelin (Specification and Price)
6.5.3 Sales Value, Gross Margin 2011-2016
6.5.4 Interviewee, Name and Contact

Purchase Complete Report at http://www.reportsweb.com/buy&RW0001271077/buy/4200

7 Technology Development Trend

8 Research Findings and Conclusion

Contact Us:                            
Call: +1-646-491-9876
Email:  sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.